Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1978 Apr;128(4):305–317.

Specialty conference: Chronic hepatitis B.

PMCID: PMC1238102  PMID: 664630

Full text

PDF
305

Images in this article

306Figure 1.
on p.306
307Figure 2.
on p.307
307Figure 3.
on p.307
307Figure 4.
on p.307
307Figure 5.
on p.307
308Figure 6.
on p.308
308Figure 7.
on p.308
308Figure 8.
on p.308
309Figure 9.
on p.309
310Figure 10.
on p.310

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker L. F., Murray R. Aquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA. 1971 Jun 21;216(12):1970–1976. [PubMed] [Google Scholar]
  2. Boyer J. L., Klatskin G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med. 1970 Nov 12;283(20):1063–1071. doi: 10.1056/NEJM197011122832001. [DOI] [PubMed] [Google Scholar]
  3. Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
  4. Dienstag J. L., Alaama A., Mosley J. W., Redeker A. G., Purcell R. H. Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med. 1977 Jul;87(1):1–6. doi: 10.7326/0003-4819-87-1-1. [DOI] [PubMed] [Google Scholar]
  5. Dietzman D. E., Matthew E. B., Madden D. L., Sever J. L., Rostafinski M., Bouton S. M., Nagler B. The occurrence of epidemic infectious hepatitis in chronic carriers of Australia antigen. J Pediatr. 1972 Apr;80(4):577–582. doi: 10.1016/s0022-3476(72)80053-2. [DOI] [PubMed] [Google Scholar]
  6. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  7. Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 2;295(10):517–522. doi: 10.1056/NEJM197609022951001. [DOI] [PubMed] [Google Scholar]
  8. HAVENS W. P., Jr Viral hepatitis: multiple attacks in a narcotic addict. Ann Intern Med. 1956 Jan;44(1):199–203. doi: 10.7326/0003-4819-44-1-199. [DOI] [PubMed] [Google Scholar]
  9. Hindman S. H., Gravelle C. R., Murphy B. L., Bradley D. W., Budge W. R., Maynard J. E. "e" Antigen, Dane particles, and serum DNA polymerase activity in HBsAg carriers. Ann Intern Med. 1976 Oct;85(4):458–460. doi: 10.7326/0003-4819-85-4-458. [DOI] [PubMed] [Google Scholar]
  10. Karvountzis G. G., Redeker A. G., Peters R. L. Long term follow-up studies of patients surviving fluminant viral hepatitis. Gastroenterology. 1974 Nov;67(5):870–877. [PubMed] [Google Scholar]
  11. Lam K. C., Tong M. J., Rakela J. Release of e antigen from a Dane particle-rich preparation of hepatitis B virus. Infect Immun. 1977 Apr;16(1):403–404. doi: 10.1128/iai.16.1.403-404.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mosley J. W., Edwards V. M., Meihaus J. E., Redeker A. G. Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol. 1972 Jun;95(6):529–535. [PubMed] [Google Scholar]
  13. Mosley J. W. Hepatitis types B and non-B. Epidemiologic background. JAMA. 1975 Sep 1;233(9):967–969. [PubMed] [Google Scholar]
  14. Mosley J. W., Redeker A. G., Feinstone S. M., Purcell R. H. Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med. 1977 Jan 13;296(2):75–78. doi: 10.1056/NEJM197701132960204. [DOI] [PubMed] [Google Scholar]
  15. Okada K., Kamiyama I., Inomata M., Imai M., Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976 Apr 1;294(14):746–749. doi: 10.1056/NEJM197604012941402. [DOI] [PubMed] [Google Scholar]
  16. Peters R. L. Viral hepatitis: a pathologic spectrum. Am J Med Sci. 1975 Jul-Aug;270(1):17–31. doi: 10.1097/00000441-197507000-00004. [DOI] [PubMed] [Google Scholar]
  17. Redeker A. G., Mosley J. W., Gocke D. J., McKee A. P., Pollack W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med. 1975 Nov 20;293(21):1055–1059. doi: 10.1056/NEJM197511202932101. [DOI] [PubMed] [Google Scholar]
  18. Redeker A. G. Viral hepatitis: clinical aspects. Am J Med Sci. 1975 Jul-Aug;270(1):9–16. doi: 10.1097/00000441-197507000-00003. [DOI] [PubMed] [Google Scholar]
  19. Robinson W. S. DNA and DNA polymerase in the core of the Dane particle of hepatitis B. Am J Med Sci. 1975 Jul-Aug;270(1):151–159. doi: 10.1097/00000441-197507000-00021. [DOI] [PubMed] [Google Scholar]
  20. Robinson W. S., Lutwick L. I. The virus of hepatitis, type B (first of two parts). N Engl J Med. 1976 Nov 18;295(21):1168–1175. doi: 10.1056/NEJM197611182952105. [DOI] [PubMed] [Google Scholar]
  21. Schalm S. W., Summerskill W. H., Gitnick G. L., Elveback L. R. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. Gut. 1976 Oct;17(10):781–786. doi: 10.1136/gut.17.10.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Skinhoj P. Hepatitis-associated antigen, subtypes D and Y. An epidemiological and clinical evaluation. Scand J Infect Dis. 1973;5(2):85–89. doi: 10.3109/inf.1973.5.issue-2.02. [DOI] [PubMed] [Google Scholar]
  23. Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
  24. Szmuness W., Hoofnagle J. H., Stevens C. E., Prince A. M. Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies. Am J Epidemiol. 1976 Sep;104(3):256–262. doi: 10.1093/oxfordjournals.aje.a112298. [DOI] [PubMed] [Google Scholar]
  25. Tapp E., Jones D. M., Hollanders D., Dymock I. W. Serial liver biopsies in blood donors with persistent HBs antigenaemia. J Clin Pathol. 1976 Oct;29(10):884–886. doi: 10.1136/jcp.29.10.884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tong M. J., Nystrom J. S., Redeker A. G., Marshall G. J. Failure to transfer-factor therapy in chronic active type B hepatitis. N Engl J Med. 1976 Jul 22;295(4):209–211. doi: 10.1056/NEJM197607222950408. [DOI] [PubMed] [Google Scholar]
  27. Tong M. J., Stevenson D., Gordon I. Correlation of e antigen, DNA polymerase activity, and Dane particles in chronic benign and chronic active type B hepatitis infections. J Infect Dis. 1977 Jun;135(6):980–984. doi: 10.1093/infdis/135.6.980. [DOI] [PubMed] [Google Scholar]
  28. Trepo C. G., Magnius L. O., Schaefer R. A., Prince A. M. Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections. Gastroenterology. 1976 Nov;71(5):804–808. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES